IRAK1 and triple-negative breast carcinoma: Deregulation/amplification at the IRAK1 locus might also not be a mechanism of choice via which tumors upregulate IRAK1 activity, though IRAK1 overexpression has been detected in several tumor types (4, 19), with particularly convincing evidence for causality in triple-negative breast cancer (52).